Naropin 0.75 % in 20 ML Injection
- RxCUI
- 905191
- RxNorm name
- Naropin 0.75 % in 20 ML Injection
- Display name
- Naropin 0.75 % in 20 ML Injection
- Full name
- Naropin 0.75 % in 20 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:50
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naropin | ROPIVACAINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | 23d2d448-a744-4877-9f2d-7e57c198da89 | 2024-08-06 | Warnings, Adverse reactions | 905191 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 23d2d448-a744-4877-9f2d-7e57c198da89 | Naropin 0.75 % in 20 ML Injection [PSN] · 20 ML ropivacaine hydrochloride 7.5 MG/ML Injection [Naropin] [SBD] · 20 ML Naropin 7.5 MG/ML Injection [SY] · Naropin 0.75 % per 20 ML Injection [SY] · Naropin 150 MG per 20 ML Injection [SY] | 5 | 27 | These highlights do not include all the information needed to use NAROPIN ® safely and effectively. See full prescribing information for NAROPIN ® . NAROPIN ® (ropivacaine hydrochloride) injection, for epidural, perineural, or infiltration use Initial U.S. Approval: 1996 Rx Only | 20240806 |